TI
CRBP icon

Trexquant Investment’s Corbus Pharmaceuticals CRBP Stock Holding History

Trexquant Investment’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,275
Closed -$222K – 1808
2025
Q4 		$222K Buy
27,275
+15,110
+124% +$186K ﹤0.01% 1505
2025
Q3 		$154K Buy
+12,165
New +$116K ﹤0.01% 1520
2024
Q3 		– Sell
-33,164
Closed -$1.5M – 1573
2024
Q2 		$1.5M Buy
33,164
+21,180
+177% +$891K 0.02% 852
2024
Q1 		$470K Buy
+11,984
New +$296K 0.01% 1166
2020
Q3 		– Sell
-2,107
Closed -$530K – 1241
2020
Q2 		$530K Buy
+2,107
New +$426K 0.04% 655
2018
Q4 		– Sell
-1,418
Closed -$321K – 1069
2018
Q3 		$321K Buy
+1,418
New +$229K 0.02% 671

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trexquant Investment's CRBP Position: Q1 2026 in Review

Trexquant Investment sold out of Corbus Pharmaceuticals (CRBP) in Q1 2026, closing a stake of 27,275 shares — an estimated $222K sold.

Trexquant Investment first reported a position in CRBP in Q3 2018 and held it in 6 quarters. The position peaked at $1.5M in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • Trexquant Investment reported no remaining Corbus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Trexquant Investment sold 27,275 Corbus Pharmaceuticals shares in Q1 2026, an estimated $222K.
  • Trexquant Investment first reported a position in Corbus Pharmaceuticals in Q3 2018 and held it in 6 quarters.
  • Trexquant Investment's Corbus Pharmaceuticals position peaked at $1.5M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.